Thermo Fisher Scientific Inc. (TMO)
NYSE
Closed
Oct 6, 2026
Day's Range
654.5152 wk Range
435.27Overview - TMO - Thermo Fisher Scientific Inc.
Key Statistics
Valuation
Enterprise Value
280.72B
P/E (Trailing)
‪35.52‬
P/E (Forward)
‪23.76‬
PEG Ratio
‪3.80‬
Price / Sales (TTM)
‪5.22‬
Price / Book
‪4.59‬
EV / EBITDA
‪23.91‬
Profitability
Gross Margin
‪40.70%‬
Profit Margin
‪15.03%‬
Operating Margin
‪18.75%‬
Return on Assets
‪5.12%‬
Return on Equity
‪13.51%‬
Ownership
Shares Outstanding
369.74M
Float
368.82M
Short % of Shares Outstanding
‪1.36%‬
Held by Insiders
‪0.13%‬
Held by Institutions
‪94.02%‬
Price stats
Beta
‪0.85‬
50-Day Avg
‪617.45‬
200-Day Avg
‪542.61‬
Dividends
Payout Ratio
‪9.68%‬
Frequency
Quarterly
Analyst Consensus
28 analysts
Average price target
‪$ 631.42‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - TMO - Thermo Fisher Scientific Inc.
Peers - TMO - Thermo Fisher Scientific Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NYSE.
Profile Summary - TMO - Thermo Fisher Scientific Inc.
About
Thermo Fisher Scientific Inc. is a global life sciences company that provides analytical instruments, laboratory products, specialty diagnostics, and biopharma services. Its portfolio supports scientific research, clinical testing, drug discovery, and pharmaceutical manufacturing through a broad range of instruments,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
